The present invention is directed to novel substituted fused aminopiperidines which are inhibitors of the dipeptidyl peptidase-IV enzyme ("DPP-IV inhibitors") and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.

 
Web www.patentalert.com

< Quinazoline derivatives and medicaments

< Pyrido [2,1-a] isoquinoline derivatives

> Triazolopyridine derivatives as inhibitors of lipases and phospholipases

> Transgenic mice generated by transposition and uses thereof

~ 00608